Business Description
Royalty Pharma PLC
NAICS : 541714
SIC : 2833
ISIN : GB00BMVP7Y09
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 1.11 | |||||
Debt-to-EBITDA | 3.96 | |||||
Interest Coverage | 7.46 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.6 | |||||
Beneish M-Score | -3.32 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -11.6 | |||||
3-Year EBITDA Growth Rate | -14.5 | |||||
3-Year EPS without NRI Growth Rate | 30.7 | |||||
3-Year FCF Growth Rate | -2.9 | |||||
3-Year Book Growth Rate | 5.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 31.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.63 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.22 | |||||
9-Day RSI | 22.92 | |||||
14-Day RSI | 28.3 | |||||
3-1 Month Momentum % | -6.75 | |||||
6-1 Month Momentum % | -4.96 | |||||
12-1 Month Momentum % | -11.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 1.54 | |||||
Cash Ratio | 1.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.38 | |||||
Dividend Payout Ratio | 0.42 | |||||
3-Year Dividend Growth Rate | 38.7 | |||||
Forward Dividend Yield % | 3.38 | |||||
5-Year Yield-on-Cost % | 3.41 | |||||
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 3.38 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 68.13 | |||||
Net Margin % | 50.53 | |||||
FCF Margin % | 123.53 | |||||
ROE % | 17.61 | |||||
ROA % | 6.81 | |||||
ROIC % | 10.12 | |||||
3-Year ROIIC % | -9.47 | |||||
ROCE % | 11.68 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.74 | |||||
Forward PE Ratio | 5.68 | |||||
PE Ratio without NRI | 12.68 | |||||
PS Ratio | 6.7 | |||||
PB Ratio | 1.61 | |||||
Price-to-Tangible-Book | 1.61 | |||||
Price-to-Free-Cash-Flow | 5.39 | |||||
Price-to-Operating-Cash-Flow | 5.39 | |||||
EV-to-EBIT | 8.87 | |||||
EV-to-Forward-EBIT | 8.16 | |||||
EV-to-EBITDA | 8.87 | |||||
EV-to-Forward-EBITDA | 8.16 | |||||
EV-to-Revenue | 7.52 | |||||
EV-to-Forward-Revenue | 6.39 | |||||
EV-to-FCF | 6.09 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Graham-Number | 0.95 | |||||
Earnings Yield (Greenblatt) % | 11.27 | |||||
FCF Yield % | 25.36 | |||||
Forward Rate of Return (Yacktman) % | -14.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Royalty Pharma PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,266.003 | ||
EPS (TTM) ($) | 2.55 | ||
Beta | 0.31 | ||
3-Year Sharpe Ratio | -0.95 | ||
3-Year Sortino Ratio | -1.1 | ||
Volatility % | 16.61 | ||
14-Day RSI | 28.3 | ||
14-Day ATR ($) | 0.490035 | ||
20-Day SMA ($) | 26.03 | ||
12-1 Month Momentum % | -11.53 | ||
52-Week Range ($) | 24.725 - 31.655 | ||
Shares Outstanding (Mil) | 444.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Royalty Pharma PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Royalty Pharma PLC Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Royalty Pharma PLC Frequently Asked Questions
What is Royalty Pharma PLC(RPRX)'s stock price today?
When is next earnings date of Royalty Pharma PLC(RPRX)?
Does Royalty Pharma PLC(RPRX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |